Clinical Trial: Preliminary Results of Chemoradiation plus Modulated RF-Hyperthermia and HDR Brachytherapy for LACC Presented at the European Society for Hyperthermic Oncology (ESHO) Congress Sapienza University Pilot Study: HyDeep 600WM efficacy in Locally Advanced Cervical Carcinoma (LACC). Authors: E. Clarke, V. De Sanctis, C. Scaringi, M. Valeriani, M. F. Osti, R. Maurizi Enrici Sant’Andrea…
Read MoreRecent Posts
- Impact of Hyperthermia on Quality of Life (QoL): Pain Relief, Fatigue Reduction, and Adjuvant Immunological Benefits
- Hyperthermia and Survival of Cancer Patients: Clinical Evidence Demonstrating an Increase in Overall Survival (OS) by Over 50%
- Therapeutic Integration of Hyperthermia in Modern Oncology: A Critical Analysis of Phase III Trials and Meta-Analyses (OS, DFS, CR Endpoints)
- Quasi feasibility study(case control) associating deep local hyperthermia treatment with standard cancer treatments and describing patterns of response ESHO
- Preliminary results of chemoradiation plus hyperthermia and high dose rate brachytherapy for locally advanced cervical carcinoma ESHO
